Primary Site >> Biliary tract Cancer
Gene >> PKM
| 1. | |||||||||||
| Journal: | Clin Transl Oncol. 2014 Feb;16(2):200-7. | ||||||||||
| Title: | PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer. | ||||||||||
| Author: | Li, J|Yang, Z|Zou, Q|Yuan, Y|Li, J|Liang, L|Zeng, G|Chen, S | ||||||||||
| PMID: | 23793810 | ||||||||||
| 2. | |||||||||||
| Journal: | Tumour Biol. 2015 Nov 6. pii: 10.1007/s13277-015-4308-z. | ||||||||||
| Title: | miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma. | ||||||||||
| Author: | Lu, Wei|Zhang, Yijian|Zhou, Linzhu|Wang, Xuan|Mu, Jiasheng|Jiang, Lin|Hu, Yunping|Dong, Ping|Liu, Yingbin | ||||||||||
| PMID: | 26546436 | ||||||||||
| 3. | |||||||||||
| Journal: | Mol Cancer. 2015 Nov 14;14:193. | ||||||||||
| Title: | PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma. | ||||||||||
| Author: | Yu, Guanzhen|Yu, Wenlong|Jin, Guangzhi|Xu, Dongyun|Chen, Ying|Xia, Tian|Yu, Allan|Fang, Wenzheng|Zhang, Xiaoli|Li, Zhaosheng|Xie, Keping | ||||||||||
| PMID: | 26576639 | ||||||||||
| 4. | |||||||||||
| Journal: | Oncotarget. 2016 Jun 21;7(25):38105-38121. | ||||||||||
| Title: | Phage display library selection of a hypoxia-binding scFv antibody for liver cancer metabolic marker discovery. | ||||||||||
| Author: | Liu, Jing|Zhang, Qing|Chen, Hang|Gao, Zhihui|Li, Yao|Sun, Zhongyuan|Xiang, Rong|Zhang, Sihe | ||||||||||
| PMID: | 27203546 | ||||||||||
| 5. | |||||||||||
| Journal: | Sci Rep. 2016 Jun 10;6:26351. | ||||||||||
| Title: | Up-regulation of PKM2 promote malignancy and related to adverse prognostic risk factor in human gallbladder cancer. | ||||||||||
| Author: | Lu, Wei|Cao, Yang|Zhang, Yijian|Li, Sheng|Gao, Jian|Wang, Xu-An|Mu, Jiasheng|Hu, Yun-Ping|Jiang, Lin|Dong, Ping|Gong, Wei|Liu, Yingbin | ||||||||||
| PMID: | 27283076 | ||||||||||
| 6. | |||||||||||
| Journal: | Oncotarget. 2017 Jan 3;8(1):1628-1640. | ||||||||||
| Title: | Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis. | ||||||||||
| Author: | Zhu, Haiyan|Luo, Hui|Zhu, Xuejie|Hu, Xiaoli|Zheng, Lihong|Zhu, Xueqiong | ||||||||||
| PMID: | 27911861 | ||||||||||
| 7. | |||||||||||
| Journal: | Oncotarget. 2018 Apr 3;9(25):17430-17442. | ||||||||||
| Title: | Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis. | ||||||||||
| Author: | Cuenco, Joy|Wehnert, Natascha|Blyuss, Oleg|Kazarian, Anna|Whitwell, Harry J|Menon, Usha|Dawnay, Anne|Manns, Michael P|Pereira, Stephen P|Timms, John F | ||||||||||
| PMID: | 29707118 | ||||||||||
| 8. | |||||||||||
| Journal: | Cell Prolif. 2018 Aug 13:e12510. | ||||||||||
| Title: | MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma. | ||||||||||
| Author: | Chen, Jianan|Yu, Yan|Chen, Xiaolong|He, Yuting|Hu, Qiuyue|Li, Hongqiang|Han, Qicai|Ren, Fang|Li, Juan|Li, Chao|Bao, Jie|Ren, Zhigang|Duan, Zhenfeng|Cui, Guangying|Sun, Ranran | ||||||||||
| PMID: | 30105813 | ||||||||||